Low-Level Resistance to Rifampin in Streptococcus pneumoniae
Rifampin is recommended for combination therapy of meningitis due to β-lactam-resistant Streptococcus pneumoniae. High-level rifampin resistance (MIC, ≥4 mg/liter) has been mapped to point mutations in clusters I and III of rpoB of the pneumococcus. The molecular basis of low-level resistance (MICs,...
Bewaard in:
| Gepubliceerd in: | Antimicrob Agents Chemother |
|---|---|
| Hoofdauteurs: | , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
American Society for Microbiology (ASM)
2003
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC149310/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12604513/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.47.3.863-868.2003 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|